Myanmar vs Thailand: HIV/AIDS deaths averted by antiretroviral therapy
Myanmar
8,848 deaths
in 2024
Thailand
10,666 deaths
in 2024
Myanmar rank
26th
Thailand rank
23rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Myanmar
- Thailand
How they compare
Thailand currently reports 10,666 deaths against 8,848 deaths in Myanmar, a difference of 1,818 deaths.
That makes Thailand's figure about 1.2 times Myanmar's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Thailand ahead.
Myanmar ranks 26th and Thailand ranks 23rd of 157 countries.
Thailand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Myanmar | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 2.7 deaths | 2.7 deaths | Thailand |
| 2000s | 792.59 deaths | 13,768 deaths | 12,976 deaths | Thailand |
| 2010s | 7,079 deaths | 21,782 deaths | 14,703 deaths | Thailand |
| 2020s | 9,387 deaths | 12,351 deaths | 2,964 deaths | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Myanmar or Thailand?
- Thailand, at 10,666 deaths against 8,848 deaths in Myanmar as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Myanmar and Thailand?
- 1,818 deaths, with Thailand ahead.
- How many years of comparable data are there for Myanmar and Thailand?
- 35 years are reported by both, from 1990 to 2024.
- How do Myanmar and Thailand rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Myanmar ranks 26th and Thailand ranks 23rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.